Fundraising Fox

Pairidex, Inc.

St. Louis, US · Founded 2023 · Delaware corporation · 2 known investors

pairidex.com ↗

Pairidex develops a tumor-informed droplet digital PCR (ddPCR) fusion assay for detecting and monitoring blood cancer, aimed at cancer surveillance and therapeutic monitoring of gene fusion-driven disease. The company works in molecular diagnostics for oncology, focusing on rare mutation detection and clonal evolution.

BiotechHealthtechMedical Devicesin /pairidex

Founders & leadership

AM
Allyson MayerInterim COO
AY
Andrew YoungFounder & CSO
PK
Paul KortschakCEO
GC
Grant ChallenCo-Founder & Scientific Advisor
TD
Todd DruleyDirector
CW
Crystal WinkelerDirector

Investors · 2

BioGenerator Ventures✓ verifiedSt. Louis · $50K – $250Kvia Crystal Winkeler · board
iSelect FundSt. Louis · $250K – $2M

Reported raises · per SEC filings

Form D private placements
▶$1.1MraisedFeb 2025 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Todd DruleyDirector
  • Crystal WinkelerDirector
  • Allyson MayerExecutive Officer
  • Andrew YoungExecutive Officer, Director
Offering amount
$1.1M
Amount sold
$1.1M
Minimum investment
$25K
First sale
May 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.